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Adenylate kinase is highly specific for AMP as phosphoryl acceptor. We have found that the replacement ofThr 39 by Ala in the chicken muscle 
enzyme, alone or together with the replacement of Leu 66 by Ile, caused remarkable increases inCMP and UMP activities with a concomitant decrease 
in AMP activity; therefore, the resulting mutant enzymes how CMP and UMP activities/AMP activity ratios much higher than the wild-type 
enzyme. The mutant enzyme in which Ala is substituted for Thr 39 has a Vma xvalue for CMP comparable to that of CMP-UMP kinase. 
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1. INTRODUCTION 
Adenylate kinase (EC 2.7.4.3) catalyzes the reversible 
phosphoryl transfer between adenine nucleotides: 
Mg-ATP + AMP ~ Mg-ADP + ADP. 
The enzyme is highly specific for AMP as phosphoryl 
acceptor; only dAMP, CMP, and UMP act as poor 
substrates ( ee Table I). Our recent mutagenesis studies 
showed that Leu 66, Va167, and Gln I°1 in the chicken 
muscle enzyme contribute to AMP binding through y- 
drophobic interactions and hydrogen-bonding [1,2]. In- 
terestingly, the replacement of Gln 1°1 by Met or His 
markedly increased the enzymatic activity for UMP [2]. 
The amino acid sequences of adenylate kinases from 
various sources how considerable similarities not only 
to each other but also to those of UMP-CMP kinases 
(EC 2.7.4. t4) from yeast [3] and slime mold [4]. We have 
considered that the difference in substrate specificities 
between two different kinases is at least partly produced 
from the substitution of the amino acid residues located 
at the nucleoside monophosphate-binding site. Actu- 
ally, Yhr  39 and Leu 66 which are conserved in many 
adenylate kinases [5] and located close to the adenine 
ring of bound AMP [6] are replaced by Ala and Ile, 
respectively, in UMP-CMP kinases. 
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Abbreviations." PCR, polymerase chain reaction; T39A and L66I, the 
single mutant enzymes in which Thr 39 and Leu 66 are separately re- 
placed by Ala and lie, respectively; T39A/L661, the double mutant 
enzyme in which Thr 39 and Leu 66 are concomitantly replaced by Ala 
and lie, respectively. 
This paper reports the nucleoside monophosphate 
specificities of single and double mutant adenylate ki- 
nases for Thr 39 and Leu 66, as well as the results of kinetic 
analysis of those mutant enzymes. 
2. EXPERIMENTAL 
The replacements of Thr 39 and Leu 66 by other amino acids were 
accomplished by oligonucleotide-directed mutagenesis of the EcoRI- 
HindIII fragment (encoding chicken adenylate kinase) excised from 
the pKK-cAK 1-1 [7] (kindly provided by Dr. A. Nakazawa of Yama- 
guchi University Medical School) and subcloned into the M13tvl9 
vector (Takara Shuzo), using synthetic six different oligonucleotide 
primers in combination, essentially as described previously [1]. The 
mutated enzyme genes were sequenced toconfirm their structures. The 
0.7-kbp fragment was inserted into plasmid pKK223-3 (Pharmacia), 
and transformed into E. coli JM109 cells. The mutant enzymes were 
purified to homogeneity, as previously described for the wild-type 
enzyme [8]. CD spectra in a region of 200-320 nm of all the mutant 
enzymes coincided well with that of the wild-type nzyme, suggesting 
the absence of gross structure changes. 
The enzyme was assayed in the standard assay mixture containing 
87 mM triethanolamine-HC1 (pH 7.0), 10 mM MgCl2, 100 mM KC1, 
1 mM phosphoenolpyruvate, 0.16mM NADH, 5 units of pyruvate 
kinase, and 20 units of lactate dehydrogenase, as described previously 
[1]. One unit of enzyme activity is defined as the amount of enzyme 
that produces 1/.tmol of ADP per minute. When nucleoside mono- 
phosphates other than AMP were used as substrate, 20 units of py- 
ruvate kinase were included. Steady state kinetic parameters were 
measured by a systematic variation in concentrations of AMP, CMP, 
or UMP as phosphoryl acceptor, with Mg-ATP as donor [1]. 
3. RESULTS 
Table I compares the specific activities of the mutant 
enzymes for AMP, dAMP, CMP, and UMP with those 
of the wild-type nzyme. (GMP and IMP did not serve 
as acceptor for both wild-type and mutant enzymes.) 
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Little decrease in AMP activity was observed for T39A, 
whereas considerable decreases appeared for L66I and 
T39A/L66I. Similar decreases were observed in dAMP 
activity by these mutations. However, the replacement 
of Thr 39 by Ala resulted in marked increases in CMP 
and UMP activities; T39A shows CMP and UMP activ- 
ities 12 and 9 times those of the wild-type enzyme, re- 
spectively. L66I and T39A/L66I having considerably 
decreased AMP activities how CMP and UMP activi- 
ties similar to those of the wild-type enzyme. Thus the 
engineered adenylate kinases, especially T39A and 
T39A/L66I, show CMP and UMP activities/AMP activ- 
ity ratio much larger than the wild-type enzyme. 
Steady state kinetic parameters of the mutant and 
wild-type enzymes were measured for AMP, CMP, and 
UMP (Table II). Interestingly, the Vmax value for AMP 
of L66I is about twice that of the wild-type enzyme, 
whereas the mutation caused an increase in the Km value 
for AMP. Other kinetic parameters of this mutant en- 
zyme are comparable to those of the wild-type enzyme. 
The increased kcat/Km values for CMP and UMP of 
T39A and T39A/L66I are attributable to both the de- 
creased K m values and the increased Vmax values; a more 
pronounced increase in the kcat/Km value of T39A is 
contributed from its Vmax value much larger than that 
of T39A/L66I. The Vm,x value of T39A for CMP is 
comparable to that of UMP-CMP kinase, although the 
Km value for CMP of T39A (7.7 mM) is much larger 
than that of UMP-CMP kinase (0.1 mM) [4]. 
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Fig. 1. Schematic drawing of the hypothetical interactions between 
AMP and chicken muscle adenylate kinase, constructed based on a 
combination of the X-ray crystallographic data [6] and the results of 
our present and previous ite-directed mutagenesis studies [1,2]. Bro- 
ken lines indicate hydrogen bonds between enzyme and AMP, and the 
shaded area corresponds to an hydrophobic region contributing to 
hydrophobic interactions between enzyme and AME 
Table I
Specific activities for nucleoside monophosphates  
Enzyme AMP dAMP CMP UMP 
unit/mg unit/mg (%) unit/mg (%) unit/mg (%) 
Wild 1900 170 (8.9) 5.7 (0.30) 
T39A 1600 32 (2.0) 66 (4.1) 
L66I 720 2.0 (0.28) 3.4 (0.47) 
T39A/L66I 120 0.27 (0.23) 19 (16) 
0.15 (0.008) 
1.3 (0.081) 
0.021 (0.003) 
0.16 (0.13) 
Specific activities for dAMP, CMP, and UMP relative to that for AMP of each enzyme are shown in parentheses. 
Table II 
Kinetic parameters for AMP, CMP, and UMP a 
Enzyme AMP CM P UMP 
K m Vmax kcat/Km K m Vma× kcat/Km Km 
(mM) (unit/mg) (s ~. mM 1) (mM) (unit/mg) (s 1. mM-1) (mM) 
Vm~x kcat/Km 
(unit/mg) (s -1 ' mM 1) 
Wild 0.17 2000 4300 21 100 1.7 33 5.0 0.053 
T39A 0.30 2200 2700 7.7 640 30 35 49 0.50 
L66I 3.0 3500 420 35 150 1.5 78 1.6 0.007 
T39A/L661 5.0 810 58 8.8 210 8.6 11 3.4 0.11 
aApparent values obtained with Mg-ATP at a fixed concentration of 2 mM. 
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4. DISCUSSION 
Diederichs and Schulz [6] suggested based on X-ray 
crystallographic data that the side-chain O atom of Ser 36 
in the bovine inner mitochondrial denylate kinase AK3 
(corresponding to Thr 39 in the chicken muscle enzyme) 
is located within a hydrogen bond-forming distance to 
the purine ring N7 atom of bound AMP. Yan et al. [9] 
also reported that Thr 39 might be located at the position 
close to the adenine ring of bound AMP but without 
forming a hydrogen bond. We have suggested in the 
site-directed mutagenesis studies that both Leu 66 and 
ga167 forming a 'hydrophobic cap' in the chicken muscle 
enzyme interact with the adenine ring of AMP and as- 
sist in determining its exact location [1,2], as in Tyr 42 
and Tyr 45 of RNase T1 that play a role of shielding the 
guanine ring from solvent [10]. 
Fig. 1 schematically illustrates the hypothetical model 
for the interactions between chicken muscle adenylate 
kinase and AMP, as constructed based on a combina- 
tion of the X-ray crystallographic data [6] and the re- 
suits of our present and previous mutagenesis studies 
[1,2]. Thr 39 locates close to the adenine ring of AMP but 
a hydrogen bond between them may not be necessary 
for AMP binding. Rather, it is tempting to speculate on 
a role for Thr 39 of hindering a pyrimidine in binding to 
the AMP-binding site; therefore, the mutation of this 
residue to Ala with a smaller side chain facilitates the 
accommodation f a pyrimidine at this site. 
Our previous finding that the replacement of Gln l°l 
by other amino acids increased the specific activity for 
UMP [2] led to try the triple mutant enzyme by a com- 
bination of the replacements of Thr 39 by Ala, Leu 66 by 
Ile, and Gln 1°1 by Asn. However, the purified enzyme 
showed a perturbed CD spectrum in a region from 200 
to 320 nm, and had very low activities for all nucleoside 
monophosphates. 
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